Early time course of heart rate variability after thrombolytic and delayed interventional therapy for acute

U Lotze1, C Ozbek, U Gerk

  • 1Department of Internal Medicine III, Friedrich Schiller University, Jena, Germany. Ulrich.Lotze@med.uni-jena.de

Cardiology
|June 9, 2000
PubMed

Insights

Heart rate variability (HRV) analysis reveals prolonged cardiac autonomic imbalance after myocardial infarction (MI), even with successful reperfusion therapy. Initial vagal hyperactivity in inferior MI quickly shifts to sympathetic activation.

Area of Science:

  • Cardiology
  • Autonomic Nervous System Research
  • Medical Diagnostics

Background:

  • Myocardial infarction (MI) significantly impacts cardiac autonomic function.
  • Assessing heart rate variability (HRV) is crucial for understanding post-MI recovery.
  • Reperfusion therapies aim to restore cardiac function but their effect on autonomic balance needs further study.

Purpose of the Study:

  • To evaluate the time course of cardiac autonomic function using heart rate variability (HRV) in patients after myocardial infarction (MI).
  • To compare HRV changes between anterior and inferior MI.
  • To investigate the impact of percutaneous coronary intervention (PCI) on HRV recovery post-MI.

Main Methods:

  • 24-hour ECG recordings were used to assess time-domain HRV parameters (SDNNi, rMSSD) in 89 MI patients.
  • Measurements were taken approximately 40 hours after chest pain onset and at 4 weeks post-MI.
  • Patients underwent thrombolysis and, if indicated, delayed early coronary angiography with PTCA.

Main Results:

  • Patients with anterior MI showed lower HRV and left ventricular ejection fraction compared to those with inferior MI.
  • Significant decreases in SDNNi and rMSSD were observed post-MI, indicating autonomic dysfunction.
  • These HRV reductions were more pronounced in inferior MI and persisted at 4 weeks, suggesting prolonged autonomic imbalance.

Conclusions:

  • Myocardial infarction leads to a prolonged cardiac autonomic imbalance, characterized by initial vagal hyperactivity followed by sympathetic activation.
  • The autonomic dysfunction recovery is slow, even after successful reperfusion therapies like PTCA.
  • HRV monitoring provides valuable insights into the complex recovery process following MI.

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...